LE WE PMID CA
Atherosclerosis (peripheral vessels)2156Atherosklerose (Periphere arterielle Verschlusskrankheit)

Ankle arm index

Atherosclerosis (Carotids and Basilaris)

Atherosclerosis (peripheral vessels)

Blood vessels (Physiology)

Brachytherapy

Buflomedil

Cardiovascular risk

CD36 FAT fatty acid translocase

Cilostazole

Endothelial dysfunction

Heart (Coronary heart disease BASKET)

Heme oxygenase

Inflammation resolution

Interleukin17

Interleukin17A

Interleukin33

Lipoprotein (HDL)

Lipoprotein (LDL)

Low back pain

Macrophages

Mast cells

Matrix metalloproteinase

Monocytes

Myeloperoxidase

Naftidrofuryl

Optical coherence tomography

Oxysterol

Pain (Neurophysiology)

Phospholipase A2

Phospholipid transfer protein

Proteasome (BASKET)

Publication issues

Receptor (oxLDL)

Receptor (PPAR gamma)

SIRT1

Sitosterolemia

Sphingosine1 phosphate

Spinal cord (Electrostimulation)

Statin

Structure det. tissue level to single molecule localization

Sudeck s dystrophy

Thrombosis (BASKET)

Transplantation

Ultrasound (intravascular)

Ultrasound and Duplexsonography

2000  
1
ABC of arterial and venous disease: Chronic lower limb ischaemia.
[10731185] BMJ 320(7238): 854-7 (2000)
1992  
2
ABC of vascular diseases. Critical leg ischaemia: amputation or reconstruction.
[1531431] BMJ 304(6822): 312-4 (1992)
2009  
3
Peripheral arterial disease: current perspectives and new trends in management.
[19864983] South Med J 102(11): 1141-9 (2009)
2006  
4
Contemporary management of peripheral arterial disease: III. Endovascular and surgical management.
[17385391] Cleve Clin J Med 73 Suppl 4(-): S45-51 (2006)
2006  
5
Contemporary management of peripheral arterial disease: II. Improving walking distance and quality of life.
[17385390] Cleve Clin J Med 73 Suppl 4(-): S38-44 (2006)
2006  
6
Contemporary management of peripheral arterial disease: I. Cardiovascular risk-factor modification.
[17385389] Cleve Clin J Med 73 Suppl 4(-): S30-7 (2006)
2006  
7
Noninvasive diagnostic strategies for peripheral arterial disease.
[17385388] Cleve Clin J Med 73 Suppl 4(-): S22-9 (2006)
2006  
8
The clinical presentation of peripheral arterial disease and guidance for early recognition.
[17385387] Cleve Clin J Med 73 Suppl 4(-): S15-21 (2006)
2006  
9
Pathophysiology of peripheral arterial disease and risk factors for its development.
[17385386] Cleve Clin J Med 73 Suppl 4(-): S8-14 (2006)
2006  
10
Peripheral arterial disease: recognition and medical management.
[16845974] Cleve Clin J Med 73(7): 621-6, 628, 632-4, passim (2006)
2008  
11
Management of peripheral arterial disease in the elderly: focus on cilostazol.
[18488875] Clin Interv Aging 3(1): 17-23 (2008)
2008  
12
Critical review of the ankle brachial index.
[19936284] Curr Cardiol Rev 4(2): 101-6 (2008)
2000  
13
Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).
[10666287] J Vasc Surg 31(1 Pt 2): S1-S296 (2000)
2009  
14
Primary nitinol stenting for femoropopliteal disease.
[19624075] J Endovasc Ther 16(2 Suppl 2): II63-81 (2009)
2009  
15
Medical and endovascular management of critical limb ischemia.
[19624074] J Endovasc Ther 16(2 Suppl 2): II31-62 (2009)
2009  
16
TASC II and the endovascular management of infrainguinal disease.
[19624072] J Endovasc Ther 16(2 Suppl 2): II5-18 (2009)
2009  
17
Past, present and future of femoropopliteal stenting.
[19317587] J Endovasc Ther 16 Suppl 1(-): I147-52 (2009)
2009  
18
Infrapopliteal stents: overview and unresolved issues.
[19317574] J Endovasc Ther 16 Suppl 1(-): I153-62 (2009)
2006  
19
Contemporary endovascular treatment for disease of the superficial femoral and popliteal arteries: an integrated device-based strategy.
[16472010] J Endovasc Ther 13 Suppl 2(-): II41-51 (2006)
2006  
20
Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries.
[16472009] J Endovasc Ther 13 Suppl 2(-): II30-40 (2006)
2006  
21
Diagnosis and risk assessment of lower extremity peripheral arterial disease.
[16472008] J Endovasc Ther 13 Suppl 2(-): II10-8 (2006)
2006  
22
Epidemiology and pathophysiology of lower extremity peripheral arterial disease.
[16472007] J Endovasc Ther 13 Suppl 2(-): II3-9 (2006)
2003  
23
Percutaneous transluminal angioplasty in the treatment of critical limb ischemia.
[12877613] J Endovasc Ther 10(2): 298-303 (2003)
2000  
24
The role of thrombolytic therapy in the management of acute and chronic lower extremity ischemia.
[10772751] J Endovasc Ther 7(1): 72-7 (2000)
1999  
25
Percutaneous transluminal angioplasty of the subclavian arteries.
[10088888] J Endovasc Surg 6(1): 33-41 (1999)
2007  
26
Risk reduction with clopidogrel in the management of peripheral arterial disease.
[17703636] Vasc Health Risk Manag 3(3): 289-97 (2007)
2007  
27
A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease.
[17462170] Health Technol Assess 11(20): iii-iv, xi-xiii, 1-184 (2007)
2002  
28
The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review.
[12022939] Health Technol Assess 6(7): 1-155 (2002)
2007  
29
Peripheral arterial disease: a guide for nephrologists.
[17699501] Clin J Am Soc Nephrol 2(4): 839-46 (2007)
1991  
30
Selection of level for lower limb amputation in patients with severe peripheral vascular disease.
[2042890] Ann R Coll Surg Engl 73(3): 148-51 (1991)
1992  
31
Endovascular surgery for peripheral arterial occlusive disease. A critical review.
[1385944] Ann Surg 216(1): 3-16 (1992)
1982  
32
Axillofemoral bypass: a ten-year review.
[6211151] Ann Surg 195(6): 796-9 (1982)
1965  
33
Review of Criteria for the Selection of the Level for Lower Extremity Amputation for Arteriosclerosis.
[17859794] Ann Surg 162(5): 886-92 (1965)
2009  
34
ACP Journal Club. Review: computed tomography angiography is highly accurate for diagnosing significant stenosis in peripheral arterial disease.
[19451568] Ann Intern Med 150(10): JC5-12 (2009)
2007  
35
In the clinic. Peripheral arterial disease.
[17339616] Ann Intern Med 146(5): ITC3-1-ITC3-16 (2007)
2008  
36
Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
[18574279] Chest 133(6 Suppl): 815S-843S (2008)
2008  
37
Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity revascularization: state of the art.
[19106409] Circulation 118(25): 2864-72 (2008)
2008  
38
Atherosclerotic Peripheral Vascular Disease Symposium II: vascular magnetic resonance and computed tomographic imaging.
[19106405] Circulation 118(25): 2837-44 (2008)
2007  
39
Endovascular therapies for peripheral arterial disease: an evidence-based review.
[17984390] Circulation 116(19): 2203-15 (2007)
2007  
40
Overview of new technologies for lower extremity revascularization.
[17967988] Circulation 116(18): 2072-85 (2007)
2006  
41
Peripheral arterial disease: morbidity and mortality implications.
[16908785] Circulation 114(7): 688-99 (2006)
2006  
42
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
[16549646] Circulation 113(11): e463-654 (2006)
1996  
43
Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review.
[8941154] Circulation 94(11): 3026-49 (1996)
1995  
44
Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists.
[7634476] Circulation 92(3): 614-21 (1995)
2009  
45
Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials.
[19028778] Eur Heart J 30(1): 44-55 (2009)
2001  
46
Lower-extremity peripheral arterial disease among patients with end-stage renal disease.
[11729255] J Am Soc Nephrol 12(12): 2838-47 (2001)
2009  
47
Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis.
[19176443] JAMA 301(4): 415-24 (2009)
2006  
48
Medical treatment of peripheral arterial disease.
[16449620] JAMA 295(5): 547-53 (2006)
2001  
49
Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis.
[11255390] JAMA 285(10): 1338-45 (2001)
2008  
50
Peripheral arterial disease: diagnosis and management.
[18674479] Mayo Clin Proc 83(8): 944-49; quiz 949-50 (2008)
1994  
51
Treatment of the critically ischaemic lower limb.
[8140023] Postgrad Med J 70(819): 5-9 (1994)
1987  
52
Angioplasty in peripheral vascular disease.
[2963265] Postgrad Med J 63(740): 435-8 (1987)
2000  
53
Update on endovascular treatment of peripheral vascular disease: new tools, techniques, and indications.
[11198311] Tex Heart Inst J 27(4): 369-85 (2000)
2000  
54
Current concepts in the evaluation of vascular disease: magnetic resonance and computed tomographic angiography.
[10928506] Tex Heart Inst J 27(2): 170-92 (2000)
2000  
55
State of the art: which stent for which lesion in peripheral interventions?
[10928499] Tex Heart Inst J 27(2): 119-26 (2000)
2000  
56
Chronic lower limb ischemia.
[10903303] West J Med 173(1): 60-3 (2000)
2007  
57
Current treatment of peripheral arterial disease: role of percutaneous interventional therapies.
[17678729] J Am Coll Cardiol 50(6): 473-90 (2007)
2006  
58
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
[16545667] J Am Coll Cardiol 47(6): 1239-312 (2006)
2004  
59
The role of infrapopliteal angioplasty.
[15569642] Br J Radiol 77(924): 1007-15 (2004)
2008  
60
MR angiography of the lower extremities.
[18492924] AJR Am J Roentgenol 190(6): 1675-84 (2008)
2005  
61
Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography.
[16304027] AJR Am J Roentgenol 185(6): 1641-50 (2005)
2000  
62
Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography.
[10628475] AJR Am J Roentgenol 174(1): 171-9 (2000)
2008  
63
Multidetector CT angiography of infrainguinal arterial bypass.
[18349456] Radiographics 28(2): 529-48; discussion 549 (2008)
2004  
64
Popliteal artery disease: diagnosis and treatment.
[15026594] Radiographics 24(2): 467-79 (2004)
2000  
65
Optimized diagnostic angiography in high-risk patients with severe peripheral vascular disease.
[10682777] Radiographics 20(1): 121-33 (2000)
2005  
66
Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis.
[15858107] Radiology 235(2): 699-708 (2005)
2000  
67
MR angiography in the evaluation of atherosclerotic peripheral vascular disease.
[10671577] Radiology 214(2): 325-38 (2000)
1997  
68
Treatment of peripheral vascular disease with stent-grafts.
[9356607] Radiology 205(2): 307-14 (1997)
2007  
69
The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.
[17933075] Acta Med Indones 39(2): 86-93 (2007)
2010  
70
The counter-regulation of atherogenesis: a role for interleukin-33.
[21171524] Acta Medica (Hradec Kralove) 53(3): 125-9 (2010)
2010  
71
Vascular calcification in animal models of CKD: A review.
[20413965] Am J Nephrol 31(6): 471-81 (2010)
2008  
72
Novel therapies for cyclic GMP control of vascular smooth muscle growth.
[19127140] Am J Ther 15(6): 551-64 (2008)
2004  
73
Osteogenic regulation of vascular calcification: an early perspective.
[15102615] Am J Physiol Endocrinol Metab 286(5): E686-96 (2004)
2006  
74
Intermittent claudication.
[17095782] BMJ 333(7576): 1002-5 (2006)
2009  
75
Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.
[19276131] BMJ 338(-): b603 (2009)
2008  
76
Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability.
[18406361] Biochim Biophys Acta 1781(5): 221-31 (2008)
2007  
77
Bilirubin and biliverdin treatment of atherosclerotic diseases.
[17245120] Cell Cycle 6(1): 39-43 (2007)
2005  
78
Conditional risk factors for atherosclerosis.
[15704777] Mayo Clin Proc 80(2): 219-30 (2005)
2002  
79
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.
[12039998] J Am Soc Nephrol 13(6): 1673-81 (2002)
2009  
80
Vascular calcification: the three-hit model.
[19470670] J Am Soc Nephrol 20(6): 1162-4 (2009)
2006  
81
Neovascularization in human atherosclerosis.
[16684874] Circulation 113(18): 2245-52 (2006)
2010  
82
Phospholipid transfer protein and atherosclerosis: genetic studies take aim at a moving target.
[20644011] Circulation 122(5): 452-4 (2010)
2010  
83
Inflammation in peripheral artery disease.
[21041698] Circulation 122(18): 1862-75 (2010)
2003  
84
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
[14530185] Circulation 108(14): 1664-72 (2003)
2003  
85
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
[14557340] Circulation 108(15): 1772-8 (2003)
2003  
86
Membrane microdomains and vascular biology: emerging role in atherogenesis.
[12732593] Circulation 107(17): 2270-3 (2003)
2007  
87
Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.
[17938300] Circulation 116(16): 1832-44 (2007)
2007  
88
Mast cells as mediators and modulators of atherogenesis.
[17502588] Circulation 115(19): 2471-3 (2007)
2005  
89
Childhood infection and endothelial dysfunction: a potential link in atherosclerosis?
[15811865] Circulation 111(13): 1568-70 (2005)
2009  
90
Insights into the role of infection in atherogenesis and in plaque rupture.
[19546396] Circulation 119(24): 3133-41 (2009)
2008  
91
Bone-marrow-derived matrix metalloproteinase-14: a novel target for plaque stability.
[18285576] Circulation 117(7): 863-5 (2008)
2008  
92
Buflomedil in peripheral arterial disease: trials and tribulations.
[18268159] Circulation 117(6): 717-9 (2008)
2010  
93
Understanding the essential role of monocytes in atherosclerosis.
[20558886] Circ J 74(7): 1292-3 (2010)
2011  
94
Role of peroxisome proliferator-activated receptor-γ in atherosclerosis: an update.
[21325726] Circ J 75(3): 528-35 (2011)
2011  
95
Advances in endovascular treatment of critical limb ischemia.
[21422665] Circ J 75(4): 756-65 (2011)
2010  
96
Macrophages, oxysterols and atherosclerosis.
[20838002] Circ J 74(10): 2045-51 (2010)
2009  
97
Critical balance of dendritic cells is destined for plaque rupture.
[19779274] Circ J 73(10): 1799-800 (2009)
2009  
98
Serial intravascular ultrasound assessment of atherosclerosis progression and regression. State-of-the-art and limitations.
[19638706] Circ J 73(9): 1557-60 (2009)
2007  
99
Targeting interferon-gamma to treat atherosclerosis.
[17702979] Circ Res 101(4): 333-4 (2007)
2007  
100
Selective depletion of macrophages in atherosclerotic plaques: myth, hype, or reality?
[17395878] Circ Res 100(6): 751-3 (2007)
2011  
101
Atherosclerosis and thrombosis: insights from large animal models.
[21274431] J Biomed Biotechnol 2011(-): 907575 (2011)
2010  
102
Microregulation of plaque neovascularization.
[20631347] Arterioscler Thromb Vasc Biol 30(8): 1500-1 (2010)
2010  
103
2005  
104
Lesion macrophages are a key target for the antiatherogenic effects of LXR agonists.
[15626767] Arterioscler Thromb Vasc Biol 25(1): 10-1 (2005)
2009  
105
Discovery of the role of wall shear in atherosclerosis.
[19038849] Arterioscler Thromb Vasc Biol 29(2): 158-61 (2009)
2007  
106
Mouse models for atherosclerosis and pharmaceutical modifiers.
[17541027] Arterioscler Thromb Vasc Biol 27(8): 1706-21 (2007)
2009  
107
2007  
108
Assessment of unstable atherosclerosis in mice.
[17332492] Arterioscler Thromb Vasc Biol 27(4): 714-20 (2007)
2007  
109
2007  
110
2005  
111
Role of caspases in death and survival of the plaque macrophage.
[15718496] Arterioscler Thromb Vasc Biol 25(5): 895-903 (2005)
2009  
112
Molecular imaging of macrophage cell death for the assessment of plaque vulnerability.
[19461053] Arterioscler Thromb Vasc Biol 29(7): 1031-8 (2009)
2010  
113
Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology.
[19679833] Arterioscler Thromb Vasc Biol 30(2): 177-81 (2010)
2005  
114
2009  
115
The discovery of cellular immunity in the atherosclerotic plaque.
[19846836] Arterioscler Thromb Vasc Biol 29(11): 1714-7 (2009)
2009  
116
Sphingosine 1-phosphate: a regulator of arterial lesions.
[19592471] Arterioscler Thromb Vasc Biol 29(10): 1439-43 (2009)
2008  
117
Role of smooth muscle cells in the initiation and early progression of atherosclerosis.
[18276911] Arterioscler Thromb Vasc Biol 28(5): 812-9 (2008)
2010  
118
On to the road to degradation: atherosclerosis and the proteasome.
[19815565] Cardiovasc Res 85(2): 291-302 (2010)
2007  
119
CD36 and macrophages in atherosclerosis.
[17442283] Cardiovasc Res 75(3): 468-77 (2007)
2007  
120
Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability.
[17084825] Cardiovasc Res 73(3): 470-80 (2007)
2008  
121
Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans.
[18430750] Cardiovasc Res 79(1): 14-23 (2008)
2008  
122
Activating SIRT1: a new strategy to prevent atherosclerosis?
[18784217] Cardiovasc Res 80(2): 163-4 (2008)
2009  
123
The unstable plaque: a broken balance.
[19561341] Eur Heart J 30(15): 1821-3 (2009)
2009  
124
Imaging of the unstable plaque: how far have we got?
[19833636] Eur Heart J 30(21): 2566-74 (2009)
2006  
125
Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
[16741184] Stroke 37(7): 1923-32 (2006)
2010  
126
From endothelial dysfunction to vascular occlusion: role of the renin-angiotensin system.
[20866008] Rev Port Cardiol 29(5): 801-24 (2010)
2004  
127
Footprints of atherosclerotic coronary heart disease in children.
[15058151] Rev Port Cardiol 23(1): 127-31 (2004)
2009  
128
Endothelial function and atherosclerosis: circulatory markers with clinical usefulness.
[20058778] Rev Port Cardiol 28(10): 1121-51 (2009)
2002  
129
2010  
130
The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
[20371550] J Lipid Res 51(8): 2058-73 (2010)
2009  
131
The LDL modification hypothesis of atherogenesis: an update.
[19011257] J Lipid Res 50 Suppl(-): S376-81 (2009)
2005  
132
Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis.
[15654120] J Lipid Res 46(3): 404-11 (2005)
2005  
133
Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis.
[15772419] J Lipid Res 46(5): 829-38 (2005)
2009  
134
Myeloperoxidase, modified lipoproteins, and atherogenesis.
[19091698] J Lipid Res 50 Suppl(-): S346-51 (2009)
2009  
135
The role of adaptive T cell immunity in atherosclerosis.
[19050311] J Lipid Res 50 Suppl(-): S364-9 (2009)
2009  
136
Mechanisms and consequences of macrophage apoptosis in atherosclerosis.
[18953058] J Lipid Res 50 Suppl(-): S382-7 (2009)
2009  
137
The role of dysfunctional HDL in atherosclerosis.
[18955731] J Lipid Res 50 Suppl(-): S145-9 (2009)
2009  
138
Emerging role of Toll-like receptors in atherosclerosis.
[18980945] J Lipid Res 50 Suppl(-): S340-5 (2009)
2011  
139
Immune mechanisms in atherosclerosis and potential for an atherosclerosis vaccine.
[21616039] Discov Med 11(60): 403-12 (2011)
2003  
140
Role of monocytes in atherogenesis.
[14506301] Physiol Rev 83(4): 1069-112 (2003)
2007  
141
Autophagy of vascular smooth muscle cells in atherosclerotic lesions.
[17172800] Autophagy 3(1): 63-4 (2007)
2007  
142
A two-carbon switch to sterol-induced autophagic death.
[17172803] Autophagy 3(1): 38-41 (2007)
2007  
143
Role of cell adhesion molecules and immune-cell migration in the initiation, onset and development of atherosclerosis.
[19262139] Cell Adh Migr 1(4): 171-5 (2007)
2008  
144
Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction.
[18160725] Clin Chem 54(1): 24-38 (2008)
2004  
145
Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications.
[15287833] Med J Aust 181(3): 150-4 (2004)
2008  
146
The role of inflammation, humoral and cell mediated autoimmunity in the pathogenesis of atherosclerosis.
[18803034] Swiss Med Wkly 138(37-38): 534-9 (2008)
2007  
147
Role of infrainguinal angioplasty in the treatment of critical limb ischaemia.
[17461306] Scand J Surg 96(1): 11-6 (2007)
2004  
148
Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents.
[15107408] J Appl Physiol 97(2): 773-80 (2004)
2010  
149
Interleukin 17 in vascular inflammation.
[21075042] Cytokine Growth Factor Rev 21(6): 463-9 (2010)
2010  
150
Macrophage death and defective inflammation resolution in atherosclerosis.
[19960040] Nat Rev Immunol 10(1): 36-46 (2010)
2010  
151
Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques.
[20439506] J Nucl Med 51(5): 663-6 (2010)
2010  
152
Imaging atherosclerosis and vulnerable plaque.
[20395341] J Nucl Med 51 Suppl 1(-): 51S-65S (2010)
2010  
153
The vascular biology of atherosclerosis and imaging targets.
[20395349] J Nucl Med 51 Suppl 1(-): 33S-37S (2010)
2008  
154
Diagnosis and treatment options for the infrapopliteal peripheric arterial occlusive diseases.
[19103542] Anadolu Kardiyol Derg 8(6): 449-50 (2008)
2004  
155
2009  
156
Endovascular treatment of femoral-popliteal disease.
[21326540] Semin Intervent Radiol 26(4): 303-14 (2009)
2010  
157
Biomarkers of peripheral arterial disease.
[20447524] J Am Coll Cardiol 55(19): 2017-23 (2010)
2008  
158
Intravascular brachytherapy for peripheral vascular disease.
[21289914] GMS Health Technol Assess 4(-): Doc08 (2008)
2008  
159
Management of lower extremity peripheral arterial disease.
[19008688] J Cardiopulm Rehabil Prev 28(6): 349-57 (2008)
PMC   
160
Our treatment strategy for critical limb ischemia.
[24386568] Int J Vasc Med 2013():437471 (2013)
PMC   
161
Systemic delivery of miR-126 by miRNA-loaded Bubble liposomes for the treatment of hindlimb ischemia.
[24457599] Sci Rep 4():3883 (2014)
PMC   
162
MRI in Lower Extremity Peripheral Arterial Disease: Recent Advancements.
[23336015] Curr Cardiovasc Imaging Rep 6(1):55-60 (2013)
PMC   
163
Outcomes of lower extremity bypass performed for acute limb ischemia.
[23714364] J Vasc Surg 58(4):949-56 (2013)
PMC   
164
An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors.
[24436577] Int J Angiol 22(1):1-8 (2013)
PMC   
165
Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia.
[24315911] J Am Coll Cardiol 63(7):682-90 (2014)
PMC   
166
Challenges associated with peripheral arterial disease in women.
[24648743] Vasc Health Risk Manag 10():115-28 (2014)
PMC   
167
Efficacy of a novel method of intravenous infusion of the prostaglandin analogue iloprost for the treatment of lower-limb critical ischemia: An open-label, nonrandomized study in two cohorts.
[24672081] Curr Ther Res Clin Exp 65(3):255-65 (2004)
PMC   
168
Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries.
[24672355] ScientificWorldJournal 2014(): (2014)
PMC   
169
Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia.
[23522155] J Vasc Interv Radiol 24(4):451-8 (2013)
PMC   
170
Multilevel versus isolated endovascular tibial interventions for critical limb ischemia.
[21803523] J Vasc Surg 54(3):722-9 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia